These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7875416)

  • 1. [Effects of atrial natriuretic factor on renal excretion of sodium in patients with liver cirrhosis].
    Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1994; 18(6-7):568-73. PubMed ID: 7875416
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
    López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J
    Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
    Jiménez W; Gutkowska J; Ginés P; Arroyo V; Rivera F; Rodés J
    Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
    Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of atrial natriuretic factor in the rats of different ages.
    Bräunlich H; Solomon S
    Physiol Bohemoslov; 1987; 36(2):119-24. PubMed ID: 2955435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance receptors for atrial natriuretic petide in Milan hypertensive and normotensive rats.
    Aptel HB; Wannop DW; al-Busada K; Henderson IW
    J Hypertens; 1996 Apr; 14(4):461-8. PubMed ID: 8761895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natriuretic peptides and the homeostasis of renal circulation in cirrhosis].
    Jiménez W
    Gastroenterol Hepatol; 1995 Nov; 18(9):477-9. PubMed ID: 8521227
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor.
    Wong F; Blendis L
    Semin Liver Dis; 1994 Feb; 14(1):59-70. PubMed ID: 8016663
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
    Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
    Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites.
    Brabant G; Jüppner H; Kirschner M; Böker K; Schmidt FW; Hesch RD
    Klin Wochenschr; 1986; 64 Suppl 6():108-11. PubMed ID: 2948056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
    Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
    Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and renal effects of human alpha atrial natriuretic peptide in two patients with congestive heart failure. A preliminary report.
    Xu CB; Jiang BQ; Wang JY; Sun NL; Chen H; Liu XR; Tian YW; Chen SJ; Li DG; Xie CW
    Chin Med J (Engl); 1986 Jan; 99(1):1-8. PubMed ID: 2942345
    [No Abstract]   [Full Text] [Related]  

  • 17. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of atrial natriuretic factor on blood pressure and renal function of long-term hypothyroid rats.
    Capasso G; Giordano DR; Capodicasa G; DeSanto NG
    Kidney Int Suppl; 1988 Sep; 25():S104-9. PubMed ID: 2972862
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
    Ahloulay M; Bankir L; Lugnier C; Le Bec A; Poirel O; Moreau R; Lebrec D
    Liver Int; 2005 Apr; 25(2):403-9. PubMed ID: 15780066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.